查看购物车
  • Traditional Chinese
  • English
  • Japanese
高级伤口护理市场（按产品、伤口类型、最终用户和地区划分）—预测至 2030 年
市场调查报告书
商品编码
1771769

高级伤口护理市场（按产品、伤口类型、最终用户和地区划分）—预测至 2030 年

Advanced Wound Care Market by Product (Dressings, NPWT, Debridement Devices, Biological Skin Substitutes, Topical Agents), Wound Type, End User, Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 376 Pages | 订单完成后即时交付

价格

全球先进伤口护理市场规模预计将从 2025 年的 133.7 亿美元增长到 2030 年的 193.2 亿美元，预测期内的复合年增长率为 7.6%。

研究范围
调查年份 2024-2030
基准年 2024
预测期 2024-2030
对价单位 金额（十亿美元）
部分 按产品、伤口类型、最终用户和地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

预计高级伤口护理市场在预测期内的复合年增长率将达到7.6%。推动该市场成长的主要因素包括糖尿病盛行率的上升、创伤和烧烫伤病例的增加，以及老年人口的扩大和慢性伤口疾病的增加。

根据最终用户，高级伤口护理市场细分为医院、高级伤口护理中心 (ASC)、创伤护理中心、居家照护机构和其他最终用户。预计到 2024 年，医院、高级伤口护理中心和创伤护理中心将占据最大的市场份额。由于糖尿病足溃疡和手术伤口的增多，高级创伤护理产品的需求主要集中在医院。此外，由于老年人口的增长以及糖尿病和血管疾病等慢性疾病的盛行率上升，医院的创伤护理护理就诊量也在增加。医院和其他高级伤口护理中心已製定了治疗方案，配备了经验丰富的医务人员，并配备了先进的伤口护理产品，可以快速有效地治疗伤口。

根据伤口类型，市场细分为手术和创伤性伤口、糖尿病足溃疡、压疮、腿部静脉溃疡以及烧伤及其他伤口。预计到2024年，手术和创伤性伤口领域将占据高级伤口护理市场的最大份额。该领域的巨大份额源于高级伤口护理产品的日益普及。高级伤口护理产品在管理这些伤口方面尤其有效，因为它们能够促进伤口更快癒合、降低感染风险并促进组织生长。由于慢性病盛行率的上升，外科手术的增加也有望促进市场成长。

全球先进伤口护理市场分为五个地区：北美、欧洲、亚太、拉丁美洲以及中东和非洲。亚太地区的成长归因于手术、道路交通事故和烧伤病例的增加，预计这些病例将影响先进伤口护理的需求。此外，糖尿病盛行率的上升和足部溃疡病例的增加也可能推动市场成长。亚太地区是一个新兴市场，为市场参与企业提供了高成长机会。

本报告研究了全球先进伤口护理市场，并根据产品、伤口类型、最终用户、地理位置和公司概况对市场进行了详细分析。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章市场概述

  • 介绍
  • 市场动态
  • 影响客户业务的趋势/中断
  • 定价分析
  • 价值链分析
  • 供应链分析
  • 生态系分析
  • 投资金筹措场景
  • 技术分析
  • 专利分析
  • 贸易分析
  • 2025-2026 年重要会议与活动
  • 案例研究分析
  • 监管状况
  • 波特五力分析
  • 主要相关人员和采购标准
  • 人工智慧对高阶伤口护理市场的影响
  • 美国关税对先进伤口护理市场的影响

第六章 先进伤口护理市场（按产品）

  • 介绍
  • 敷料
  • 设备和配件
  • 生物皮肤替代品
  • 局部药物

7. 先进伤口护理市场（依伤口类型）

  • 介绍
  • 手术/创伤伤口
  • 糖尿病足溃疡
  • 压疮
  • 静脉性腿部溃疡
  • 烧伤等

8. 高级伤口护理市场（按最终用户）

  • 介绍
  • 医院、ASCS、创伤护理中心
  • 居家照护
  • 其他的

第九章 先进伤口护理市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 新加坡
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 医疗设施需求的不断增长推动了市场
    • 中东和非洲宏观经济展望

第十章 竞争格局

  • 概述
  • 2024年主要参与企业的策略/优势
  • 2022-2024年收益分析
  • 2024年市场占有率分析
  • 公司估值矩阵：2024 年主要参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 估值和财务指标
  • 品牌/产品比较
  • 竞争场景

第十一章 公司简介

  • 主要参与企业
    • SOLVENTUM
    • SMITH+NEPHEW
    • MOLNLYCKE AB
    • CONVATEC GROUP PLC
    • COLOPLAST GROUP
    • ORGANOGENESIS INC.
    • PAUL HARTMANN AG
    • CARDINAL HEALTH
    • MIMEDX GROUP, INC.
    • OWENS & MINOR
    • B. BRAUN SE
    • ESSITY AKTIEBOLAG
    • INTEGRA LIFESCIENCES CORPORATION
    • AVERY DENNISON CORPORATION
    • MATIV HOLDINGS, INC.
    • BIOVENTUS
    • ZIMMER BIOMET
  • 其他公司
    • LOHMANN & RAUSCHER GMBH & CO. KG
    • MEDLINE INDUSTRIES, LP
    • DEROYAL INDUSTRIES, INC.
    • WINNER MEDICAL CO., LTD.
    • ADVANCIS（UK）
    • MIL LABORATORIES PVT. LTD.
    • PENSAR MEDICAL
    • HAROMED BV
    • URGO GROUP
    • DIRECT HEALTHCARE GROUP
    • DERMARITE INDUSTRIES, LLC.
    • MEDAXIS LLC
    • GENTELL

第十二章 附录

Product Code: MD 3838

The global advanced wound care market is projected to reach USD 19.32 billion by 2030 from USD 13.37 billion in 2025, at a CAGR of 7.6% during the forecast period."

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Wound Type, and End User
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

The advanced wound care market is projected to grow at a CAGR of 7.6% during the forecast period. The key factors contributing to the market growth include the increasing prevalence of diabetes, the rising cases of traumatic & burn injuries, and the expanding geriatric population with a subsequent rise in chronic wound conditions.

By end user, the hospitals, ASCs, and wound care centers segment accounted for the largest share of the market in 2024.

By end user, the advanced wound care market is segmented into hospitals, ASCs, and wound care centers; home care settings; and other end users. In 2024, the hospitals, ASCs, and wound care centers segment accounted for the largest share of the market in 2024. The rising incidence of diabetic foot ulcers and surgical wounds primarily causes the need for advanced wound care products in hospitals. Hospital visits for wound care have also increased owing to the expanding geriatric population and the increasing incidence of chronic conditions, such as diabetes and vascular diseases. Hospitals and other advanced wound care centers can treat wounds quickly & effectively due to established protocols, knowledgeable medical staff, and the availability of advanced wound care products.

By wound type, the surgical & traumatic wounds segment accounted for the largest market share in 2024.

The market is segmented by wound type into surgical & traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns & other wounds. The surgical & traumatic wounds segment accounted for the largest share of the advanced wound care market in 2024. The large share of this segment is attributed to the availability of advanced wound care products, which are particularly effective in managing these wounds, as they promote quicker recovery, reduce infection risks, and improve tissue growth. The increasing number of surgical procedures owing to the rising incidence of chronic diseases is also expected to contribute to market growth.

By region, the Asia Pacific is expected to grow at the highest CAGR during the forecast period.

The global advanced wound care market is segmented into five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The growth of the Asia Pacific region can be attributed to the rising number of surgeries, road accidents, and burn cases, which is expected to influence the demand for advanced wound care therapies. The growing incidence of diabetes and rising cases of foot ulcers is also likely to fuel market growth. The Asia Pacific region offers high growth opportunities for players in the market owing to emerging growth economies.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35%
  • By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
  • By Region: North America: 50%, Europe: 20%, the Asia Pacific: 20%, Latin America: 7%, and the Middle East & Africa: 3%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The key players operating in the advanced wound care market are Solventum (US), Smith+ Nephew (UK), Molnlycke AB (Sweden), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), B.Braun SE (Germany), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Essity, Aktiebolag (Sweden), AVERY DENNISON CORPORATION (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), Zimmer Biomet (US), and Bioventus (US).

Research Coverage

This report studies the advanced wound care market based on product, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments pertaining to five regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights into the following pointers:

  • Analysis of key drivers (growing geriatric population, increasing cases of traumatic injuries, growing prevalence of chronic diseases,

the rising incidence of burn injuries, and supportive

government initiatives & reimbursement policies), restraints (high cost of advanced wound care products and the risks associated with the use of advanced wound care products), opportunities (Emerging economies and the rising technological advancements in advanced wound care products), and challenges (shortage of trained professionals and limited awareness of advanced wound care products in rural areas)

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the advanced wound care market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the advanced wound care market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the advanced wound care market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
      • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.2.1.3 Approach 3: Primary interviews
      • 2.2.1.4 Growth forecast
      • 2.2.1.5 CAGR projections
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
    • 2.4.1 STUDY-RELATED ASSUMPTIONS
    • 2.4.2 PARAMETRIC ASSUMPTIONS
    • 2.4.3 GROWTH RATE ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
  • 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ADVANCED WOUND CARE MARKET
  • 4.2 ASIA PACIFIC: ADVANCED WOUND CARE MARKET SHARE, BY END USER AND COUNTRY
  • 4.3 ADVANCED WOUND CARE MARKET, BY KEY COUNTRY
  • 4.4 ADVANCED WOUND CARE MARKET, BY REGION, 2025 VS. 2030

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing geriatric population
      • 5.2.1.2 Increasing cases of traumatic injuries
      • 5.2.1.3 Growing prevalence of chronic diseases
      • 5.2.1.4 Rising incidence of burn injuries
      • 5.2.1.5 Government initiatives and reimbursement policies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of advanced wound care products
      • 5.2.2.2 Risks associated with use of advanced wound care products
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging economies
      • 5.2.3.2 Technological advancement in wound care
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of trained healthcare professionals
      • 5.2.4.2 Limited awareness in underdeveloped regions
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
    • 5.4.2 AVERAGE SELLING PRICE TREND, BY WOUND TYPE
    • 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Negative pressure wound therapy
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Micropore particle technology
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Telemedicine and mobile health (MHealth)
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 IMPORT DATA (HS CODE 300510)
    • 5.11.2 EXPORT DATA (HS CODE 300510)
  • 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.13 CASE STUDY ANALYSIS
    • 5.13.1 CASE STUDY 1: COMPLEX WOUND HEALING WITH TOPICAL ADVANCED WOUND CARE
    • 5.13.2 CASE STUDY 2: EVALUATION OF NEW HYDROCOLL HYDROCOLLOID DRESSING IN WOUND CARE
    • 5.13.3 CASE STUDY 3: SUPPORTED SELF-MANAGEMENT OF HARD-TO-HEAL PRESSURE ULCERS USING A SIMPLE 3-STEP FRAMEWORK DEVELOPED BY COLOPLAST
  • 5.14 REGULATORY LANDSCAPE
    • 5.14.1 REGULATORY ANALYSIS
      • 5.14.1.1 North America
        • 5.14.1.1.1 US
        • 5.14.1.1.2 Canada
      • 5.14.1.2 Europe
        • 5.14.1.2.1 Germany
        • 5.14.1.2.2 UK
        • 5.14.1.2.3 France
      • 5.14.1.3 Asia Pacific
        • 5.14.1.3.1 China
        • 5.14.1.3.2 Japan
        • 5.14.1.3.3 India
      • 5.14.1.4 Latin America
      • 5.14.1.5 Middle East
    • 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.14.2.1 North America
      • 5.14.2.2 Europe
      • 5.14.2.3 Asia Pacific
      • 5.14.2.4 Latin America
      • 5.14.2.5 Rest of the World
  • 5.15 PORTER'S FIVE FORCES ANALYSIS
    • 5.15.1 BARGAINING POWER OF SUPPLIERS
    • 5.15.2 BARGAINING POWER OF BUYERS
    • 5.15.3 THREAT OF NEW ENTRANTS
    • 5.15.4 THREAT OF SUBSTITUTES
    • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 IMPACT OF AI ON ADVANCED WOUND CARE MARKET
    • 5.17.1 INTRODUCTION
    • 5.17.2 MARKET POTENTIAL OF AI IN ADVANCED WOUND CARE MARKET
    • 5.17.3 AI USE CASES
    • 5.17.4 KEY COMPANIES IMPLEMENTING AI
    • 5.17.5 FUTURE OF AI IN ADVANCED WOUND CARE MARKET
  • 5.18 IMPACT OF US TARIFF REGULATION ON ADVANCED WOUND CARE MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 KEY TARIFF RATES
    • 5.18.3 PRICE IMPACT ANALYSIS
    • 5.18.4 KEY IMPACTS ON COUNTRY/REGION
      • 5.18.4.1 North America
      • 5.18.4.2 Europe
      • 5.18.4.3 Asia Pacific
    • 5.18.5 IMPACT ON END-USE INDUSTRIES
      • 5.18.5.1 Hospitals, ASCs, and wound care centers

6 ADVANCED WOUND CARE MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 DRESSINGS
    • 6.2.1 FOAM DRESSINGS
      • 6.2.1.1 Silicone dressings
        • 6.2.1.1.1 Ability to expedite wound closure and reduce risk of maceration to drive market
      • 6.2.1.2 Non-silicone dressings
        • 6.2.1.2.1 Advantages such as scar removal and wound healing to drive demand
    • 6.2.2 HYDROCOLLOID DRESSINGS
      • 6.2.2.1 Ability to promote granulation and formation of new tissues in open wounds to boost adoption
    • 6.2.3 FILM DRESSINGS
      • 6.2.3.1 Non-absorbable nature of film dressings to limit adoption
    • 6.2.4 ALGINATE DRESSINGS
      • 6.2.4.1 Growing incidence of pressure and diabetic foot ulcers to fuel growth
    • 6.2.5 HYDROGEL DRESSINGS
      • 6.2.5.1 Ability to provide relief and cooling effect on skin to drive use of hydrogel dressings
    • 6.2.6 COLLAGEN DRESSINGS
      • 6.2.6.1 Favorable reimbursement scenario for collagen dressings to support market
    • 6.2.7 HYDROFIBER DRESSINGS
      • 6.2.7.1 Combination of properties of hydrocolloids and alginates to boost adoption of hydrofiber dressings
    • 6.2.8 WOUND CONTACT LAYERS
      • 6.2.8.1 Ability to protect wound beds from bacterial and fungal growth to drive growth
    • 6.2.9 SUPERABSORBENT DRESSINGS
      • 6.2.9.1 Use of superabsorbent dressings for fragile skin to promote growth
    • 6.2.10 OTHER ADVANCED DRESSINGS
  • 6.3 DEVICES & ACCESSORIES
    • 6.3.1 NPWT DEVICES & ACCESSORIES
      • 6.3.1.1 Growing adoption of single-use NPWT devices in home care to drive growth
    • 6.3.2 DEBRIDEMENT DEVICES & ACCESSORIES
      • 6.3.2.1 Development of novel technologies to drive market
    • 6.3.3 WOUND ASSESSMENT & MONITORING DEVICES
      • 6.3.3.1 Potential cost-reducing capabilities of wound assessment & monitoring devices to boost adoption
    • 6.3.4 OTHER DEVICES & ACCESSORIES
  • 6.4 BIOLOGICAL SKIN SUBSTITUTES
    • 6.4.1 HUMAN DONOR TISSUE-DERIVED PRODUCTS
      • 6.4.1.1 High efficacy of human donor tissue-derived products to support market demand
    • 6.4.2 ACELLULAR ANIMAL-DERIVED PRODUCTS
      • 6.4.2.1 Recognition of importance of ECM in wound treatment to drive development of acellular wound care biologics
    • 6.4.3 BIOSYNTHETIC PRODUCTS
      • 6.4.3.1 Increased bioburden of infected wounds to drive development of biosynthetic wound care products
  • 6.5 TOPICAL AGENTS
    • 6.5.1 COST-EFFECTIVENESS AND EASE OF USE IN HOME CARE SETTINGS TO DRIVE DEMAND

7 ADVANCED WOUND CARE MARKET, BY WOUND TYPE

  • 7.1 INTRODUCTION
  • 7.2 SURGICAL & TRAUMATIC WOUNDS
    • 7.2.1 RISING VOLUME OF SURGICAL PROCEDURES TO DRIVE MARKET
  • 7.3 DIABETIC FOOT ULCERS
    • 7.3.1 RISING DIABETES INCIDENCE TO DRIVE MARKET
  • 7.4 PRESSURE ULCERS
    • 7.4.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET
  • 7.5 VENOUS LEG ULCERS
    • 7.5.1 RISING PREVALENCE OF OBESITY TO DRIVE MARKET
  • 7.6 BURNS & OTHER WOUNDS
    • 7.6.1 HIGH INCIDENCE OF BURN INJURIES IN DEVELOPING REGIONS TO SUPPORT MARKET GROWTH

8 ADVANCED WOUND CARE MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS, ASCS, AND WOUND CARE CENTERS
    • 8.2.1 INCREASING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE GROWTH
  • 8.3 HOME CARE SETTINGS
    • 8.3.1 DECREASED COSTS AND HIGHER CONVENIENCE AND COMFORT OF HOME CARE TO ENSURE MARKET GROWTH
  • 8.4 OTHER END USERS

9 ADVANCED WOUND CARE MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 Rising diabetes prevalence and supportive reimbursement policies to drive market
    • 9.2.3 CANADA
      • 9.2.3.1 Government-backed efforts supporting market development
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Germany sees rising diabetes cases and chronic wound burden
    • 9.3.3 UK
      • 9.3.3.1 Increase in R&D activity to drive market
    • 9.3.4 FRANCE
      • 9.3.4.1 Rising chronic wound cases to drive market expansion
    • 9.3.5 ITALY
      • 9.3.5.1 Emerging market for advanced wound care in Europe
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising life expectancy and aging population to drive demand
    • 9.3.7 RUSSIA
      • 9.3.7.1 Government initiatives to raise diabetes awareness to support market expansion
    • 9.3.8 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 CHINA
      • 9.4.2.1 Increasing incidence of diabetic foot ulcers (DFUs) to drive growth
    • 9.4.3 JAPAN
      • 9.4.3.1 Evolving healthcare delivery and infrastructure landscape to fuel market
    • 9.4.4 INDIA
      • 9.4.4.1 Booming medical tourism to speed up growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Growing medical manufacturing companies to drive market
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Increasing healthcare spending to sustain growth
    • 9.4.7 SINGAPORE
      • 9.4.7.1 Increasing awareness and focus on advanced wound care therapies to facilitate growth
    • 9.4.8 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Largest healthcare sector to drive market
    • 9.5.3 MEXICO
      • 9.5.3.1 Expanding hospital infrastructure to aid growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ADVANCED WOUND CARE MARKET
  • 10.3 REVENUE ANALYSIS, 2022-2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Product footprint
      • 10.5.5.4 Wound type footprint
      • 10.5.5.5 End user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of key startups/SMEs
  • 10.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 10.7.1 COMPANY VALUATION
    • 10.7.2 FINANCIAL METRICS
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS
    • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 SOLVENTUM
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products/Solutions/Services offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches & approvals
        • 11.1.1.3.2 Other developments
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 SMITH+NEPHEW
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products/Solutions/Services offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches & approvals
        • 11.1.2.3.2 Deals
        • 11.1.2.3.3 Expansions
        • 11.1.2.3.4 Other developments
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 MOLNLYCKE AB
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products/Solutions/Services offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Deals
        • 11.1.3.3.2 Other developments
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 CONVATEC GROUP PLC
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products/Solutions/Services offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product launches & approvals
        • 11.1.4.3.2 Deals
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 COLOPLAST GROUP
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products/Solutions/Services offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product launches & approvals
        • 11.1.5.3.2 Deals
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 ORGANOGENESIS INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products/Solutions/Services offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches & approvals
        • 11.1.6.3.2 Expansions
    • 11.1.7 PAUL HARTMANN AG
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products/Solutions/Services offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Deals
    • 11.1.8 CARDINAL HEALTH
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products/Solutions/Services offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Deals
        • 11.1.8.3.2 Expansions
    • 11.1.9 MIMEDX GROUP, INC.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products/Solutions/Services offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product launches & approvals
    • 11.1.10 OWENS & MINOR
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products/Solutions/Services offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Deals
        • 11.1.10.3.2 Other developments
    • 11.1.11 B. BRAUN SE
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products/Solutions/Services offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Expansions
        • 11.1.11.3.2 Other developments
    • 11.1.12 ESSITY AKTIEBOLAG
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products/Solutions/Services offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Other developments
    • 11.1.13 INTEGRA LIFESCIENCES CORPORATION
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products/Solutions/Services offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Product launches & approvals
        • 11.1.13.3.2 Other developments
    • 11.1.14 AVERY DENNISON CORPORATION
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products/Solutions/Services offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Expansions
    • 11.1.15 MATIV HOLDINGS, INC.
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products/Solutions/Services offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Deals
    • 11.1.16 BIOVENTUS
      • 11.1.16.1 Business overview
      • 11.1.16.2 Products/Solutions/Services offered
      • 11.1.16.3 Recent developments
        • 11.1.16.3.1 Deals
        • 11.1.16.3.2 Other developments
    • 11.1.17 ZIMMER BIOMET
      • 11.1.17.1 Business overview
      • 11.1.17.2 Products/Solutions/Services offered
      • 11.1.17.3 Recent developments
        • 11.1.17.3.1 Deals
  • 11.2 OTHER PLAYERS
    • 11.2.1 LOHMANN & RAUSCHER GMBH & CO. KG
    • 11.2.2 MEDLINE INDUSTRIES, LP
    • 11.2.3 DEROYAL INDUSTRIES, INC.
    • 11.2.4 WINNER MEDICAL CO., LTD.
    • 11.2.5 ADVANCIS (UK)
    • 11.2.6 MIL LABORATORIES PVT. LTD.
    • 11.2.7 PENSAR MEDICAL
    • 11.2.8 HAROMED BV
    • 11.2.9 URGO GROUP
    • 11.2.10 DIRECT HEALTHCARE GROUP
    • 11.2.11 DERMARITE INDUSTRIES, LLC.
    • 11.2.12 MEDAXIS LLC
    • 11.2.13 GENTELL

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ADVANCED WOUND CARE MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 ADVANCED WOUND CARE WOUND CARE MARKET: RISK ASSESSMENT
  • TABLE 3 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023
  • TABLE 4 ROAD ACCIDENT DEMOGRAPHIC, 2022
  • TABLE 5 CHINA: STATES ON DISCHARGE OF PATIENTS WITH TYPE 2 DFU IN DIFFERENT AGE GROUPS, JANUARY 2017-DECEMBER 2023
  • TABLE 6 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS
  • TABLE 7 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023-2024
  • TABLE 8 AVERAGE SELLING PRICING TREND OF ADVANCED WOUND CARE PRODUCTS, 2023-2025
  • TABLE 9 AVERAGE SELLING PRICE TREND AMONG KEY PLAYERS, BY WOUND TYPE, 2023-2025
  • TABLE 10 AVERAGE SELLING PRICE TREND KEY PLAYERS, BY REGION, 2023-2025
  • TABLE 11 ADVANCED WOUND CARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 12 ADVANCED WOUND CARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023-2025
  • TABLE 13 IMPORT DATA (HS CODE 300510), BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 14 EXPORT DATA (HS CODE 300510), BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 15 ADVANCED WOUND CARE MARKET: KEY CONFERENCES AND EVENTS, APRIL 2025-DECEMBER 2026
  • TABLE 16 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
  • TABLE 17 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 ADVANCED WOUND CARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ADVANCED WOUND CARE PRODUCTS (%)
  • TABLE 24 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS
  • TABLE 25 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 26 ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 27 ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 28 ADVANCED WOUND CARE DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 29 NORTH AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 LATIN AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 KEY PRODUCTS IN FOAM DRESSINGS MARKET
  • TABLE 34 FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 35 FOAM DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 36 NORTH AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 EUROPE: FOAM DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 LATIN AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 SILICONE DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 41 NORTH AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 EUROPE: SILICONE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: SILICONE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 LATIN AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 NON-SILICONE DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 EUROPE: NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 LATIN AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 KEY PRODUCTS IN HYDROCOLLOID DRESSINGS MARKET
  • TABLE 51 HYDROCOLLOID DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 NORTH AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 EUROPE: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 LATIN AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 KEY PRODUCTS IN FILM DRESSINGS MARKET
  • TABLE 57 FILM DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: FILM DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 EUROPE: FILM DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: FILM DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 LATIN AMERICA: FILM DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 KEY PRODUCTS IN ALGINATE DRESSINGS MARKET
  • TABLE 63 ALGINATE DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 KEY PRODUCTS IN HYDROGEL DRESSINGS MARKET
  • TABLE 69 HYDROGEL DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 EUROPE: HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 73 LATIN AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 KEY PRODUCTS IN COLLAGEN DRESSINGS MARKET
  • TABLE 75 COLLAGEN DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 80 KEY PRODUCTS IN HYDROFIBER DRESSINGS MARKET
  • TABLE 81 HYDROFIBER DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 83 EUROPE: HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 LATIN AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 KEY PRODUCTS IN WOUND CONTACT LAYERS MARKET
  • TABLE 87 WOUND CONTACT LAYERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 88 NORTH AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 EUROPE: WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 LATIN AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 92 KEY PRODUCTS IN SUPERABSORBENT DRESSINGS MARKET
  • TABLE 93 SUPERABSORBENT DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 94 NORTH AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 95 EUROPE: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 97 LATIN AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 KEY PRODUCTS IN OTHER ADVANCED DRESSINGS MARKET
  • TABLE 99 OTHER ADVANCED DRESSINGS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 100 NORTH AMERICA: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 101 EUROPE: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 103 LATIN AMERICA: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 DEVICES & ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 106 NORTH AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 107 EUROPE: DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 109 LATIN AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 KEY PRODUCTS IN NPWT DEVICES & ACCESSORIES MARKET
  • TABLE 111 NPWT DEVICES & ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 112 NORTH AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 EUROPE: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 115 LATIN AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 KEY PRODUCTS IN DEBRIDEMENT DEVICES & ACCESSORIES MARKET
  • TABLE 117 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 118 NORTH AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 119 EUROPE: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 121 LATIN AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 KEY PRODUCTS IN WOUND ASSESSMENT & MONITORING DEVICES MARKET
  • TABLE 123 WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 124 NORTH AMERICA: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 EUROPE: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 127 LATIN AMERICA: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 KEY PRODUCTS IN OTHER DEVICES & ACCESSORIES MARKET
  • TABLE 129 OTHER DEVICES & ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 130 NORTH AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 EUROPE: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 133 LATIN AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 134 KEY PRODUCTS IN BIOLOGICAL SKIN SUBSTITUTES MARKET
  • TABLE 135 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 136 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 137 NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 138 EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 140 LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 141 KEY PRODUCTS IN HUMAN DONOR TISSUE MARKET
  • TABLE 142 HUMAN DONOR TISSUE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 143 KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED MARKET
  • TABLE 144 ACELLULAR ANIMAL-DERIVED MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 145 KEY PRODUCTS IN BIOSYNTHETIC MARKET
  • TABLE 146 BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 147 KEY PRODUCTS IN TOPICAL AGENTS MARKET
  • TABLE 148 TOPICAL AGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 149 NORTH AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 150 EUROPE: TOPICAL AGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: TOPICAL AGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 152 LATIN AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 153 ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 155 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 156 EUROPE: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 158 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 159 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2024 (USD MILLION)
  • TABLE 160 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (THOUSANDS)
  • TABLE 161 ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 162 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 163 EUROPE: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 165 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 166 ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 167 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 168 EUROPE: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 170 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 171 ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 172 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 173 EUROPE ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 175 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 176 ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 177 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 178 EUROPE: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 180 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 181 ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 182 HOSPITALS PER CAPITA, BY COUNTRY, 2024
  • TABLE 183 ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 184 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 185 EUROPE: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 187 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 188 ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 189 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 190 EUROPE: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 193 ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 194 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 195 EUROPE: ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 196 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 197 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 198 ADVANCED WOUND CARE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 199 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 200 NORTH AMERICA: ADVANCED WOUND CARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 201 NORTH AMERICA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 202 NORTH AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 203 NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 NORTH AMERICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 205 NORTH AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 NORTH AMERICA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 207 US: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 208 US: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 US: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 US: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 211 US: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 US: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 213 ESTIMATED PREVALENCE AND COST OF DIABETES
  • TABLE 214 CANADA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 215 CANADA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 216 CANADA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 217 CANADA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 218 CANADA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 219 CANADA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 220 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 221 EUROPE: ADVANCED WOUND CARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 222 EUROPE: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 223 EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 EUROPE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 EUROPE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 EUROPE: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 228 GERMANY: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 229 GERMANY: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 230 GERMANY: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 GERMANY: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 232 GERMANY: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 GERMANY: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 234 UK: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 235 UK: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 236 UK: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 237 UK: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 UK: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 UK: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 240 FRANCE: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 241 FRANCE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 242 FRANCE: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 243 FRANCE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 244 FRANCE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 FRANCE: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 246 ITALY: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 247 ITALY: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 ITALY: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 249 ITALY: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 ITALY: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 251 ITALY: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 252 SPAIN: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 253 SPAIN: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 254 SPAIN: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 SPAIN: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 SPAIN: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 SPAIN: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 258 RUSSIA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 259 RUSSIA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 260 RUSSIA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 RUSSIA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 RUSSIA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 263 RUSSIA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 264 REST OF EUROPE: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 265 REST OF EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 266 REST OF EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 REST OF EUROPE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 268 REST OF EUROPE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 269 REST OF EUROPE: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 270 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
  • TABLE 271 ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 272 ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 273 ASIA PACIFIC: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 274 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 276 ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 277 ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 278 CHINA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 279 CHINA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 280 CHINA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 281 CHINA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 282 CHINA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 283 CHINA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 284 JAPAN: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 285 JAPAN: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 286 JAPAN: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 287 JAPAN: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 288 JAPAN: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 289 JAPAN: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 290 INDIA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 291 INDIA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 292 INDIA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 293 INDIA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 294 INDIA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 295 INDIA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 296 AUSTRALIA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 297 AUSTRALIA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 298 AUSTRALIA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 299 AUSTRALIA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 300 AUSTRALIA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 301 AUSTRALIA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 302 SOUTH KOREA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 303 SOUTH KOREA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 304 SOUTH KOREA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 305 SOUTH KOREA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 306 SOUTH KOREA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 307 SOUTH KOREA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 308 SINGAPORE: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 309 SINGAPORE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 310 SINGAPORE: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 311 SINGAPORE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 312 SINGAPORE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 313 SINGAPORE: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 314 REST OF ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 315 REST OF ASIA PACIFIC: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 316 REST OF ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 317 REST OF ASIA PACIFIC: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 318 REST OF ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 319 REST OF ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 320 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 321 LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 322 LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 323 LATIN AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 324 LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 325 LATIN AMERICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 326 LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 327 LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 328 BRAZIL: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 329 BRAZIL: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 330 BRAZIL: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 331 BRAZIL: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 332 BRAZIL: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 333 BRAZIL: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 334 MEXICO: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 335 MEXICO: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 336 MEXICO: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 337 MEXICO: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 338 MEXICO: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 339 MEXICO: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 340 REST OF LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 341 REST OF LATIN AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 342 REST OF LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 343 REST OF LATIN AMERICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 344 REST OF LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 345 REST OF LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 346 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
  • TABLE 347 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 348 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 349 MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 350 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 351 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 352 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 353 ADVANCED WOUND CARE MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2022-APRIL 2025
  • TABLE 354 ADVANCED WOUND CARE MARKET: DEGREE OF COMPETITION
  • TABLE 355 ADVANCED WOUND CARE MARKET: REGION FOOTPRINT
  • TABLE 356 ADVANCED WOUND CARE MARKET: PRODUCT FOOTPRINT
  • TABLE 357 ADVANCED WOUND CARE MARKET: WOUND TYPE FOOTPRINT
  • TABLE 358 ADVANCED WOUND CARE MARKET: END USER FOOTPRINT
  • TABLE 359 ADVANCED WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 360 ADVANCED WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 361 ADVANCED WOUND CARE MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 362 ADVANCED WOUND CARE MARKET: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 363 ADVANCED WOUND CARE MARKET: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 364 ADVANCED WOUND CARE MARKET: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 365 SOLVENTUM: COMPANY OVERVIEW
  • TABLE 366 SOLVENTUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 367 SOLVENTUM: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 368 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 369 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 370 SMITH+NEPHEW: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 371 SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 372 SMITH+NEPHEW: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 373 SMITH+NEPHEW: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 374 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 375 MOLNLYCKE AB: COMPANY OVERVIEW
  • TABLE 376 MOLNLYCKE AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 377 MOLNLYCKE AB: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 378 MOLNLYCKE AB: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 379 CONVATEC GROUP PLC: COMPANY OVERVIEW
  • TABLE 380 CONVATEC GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 381 CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 382 CONVATEC GROUP PLC: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 383 COLOPLAST GROUP: COMPANY OVERVIEW
  • TABLE 384 COLOPLAST GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 385 COLOPLAST GROUP: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 386 COLOPLAST GROUP: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 387 ORGANOGENESIS INC.: COMPANY OVERVIEW
  • TABLE 388 ORGANOGENESIS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 389 ORGANOGENESIS INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 390 ORGANOGENESIS INC.: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 391 PAUL HARTMANN AG: COMPANY OVERVIEW
  • TABLE 392 PAUL HARTMANN AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 393 PAUL HARTMANN AG: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 394 CARDINAL HEALTH: COMPANY OVERVIEW
  • TABLE 395 CARDINAL HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 396 CARDINAL HEALTH: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 397 CARDINAL HEALTH: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 398 MIMEDX GROUP, INC.: COMPANY OVERVIEW
  • TABLE 399 MIMEDX GROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 400 MIMEDX GROUP, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 401 OWENS & MINOR: COMPANY OVERVIEW
  • TABLE 402 OWENS & MINOR: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 403 OWENS & MINOR: DEALS, JANUARY 2022-JANUARY 2025
  • TABLE 404 OWENS & MINOR: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 405 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 406 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 407 B. BRAUN SE: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 408 B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 409 ESSITY AKTIEBOLAG: COMPANY OVERVIEW
  • TABLE 410 ESSITY AKTIEBOLAG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 411 ESSITY AKTIEBOLAG: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 412 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 413 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 414 INTEGRA LIFESCIENCES CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 415 INTEGRA LIFESCIENCES CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 416 AVERY DENNISON CORPORATION: COMPANY OVERVIEW
  • TABLE 417 AVERY DENNISON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 418 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 419 MATIV HOLDINGS, INC.: COMPANY OVERVIEW
  • TABLE 420 MATIV HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 421 MATIV HOLDINGS, INC.: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 422 BIOVENTUS: COMPANY OVERVIEW
  • TABLE 423 BIOVENTUS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 424 BIOVENTUS: DEALS, JANUARY 2022-JANUARY 2025
  • TABLE 425 BIOVENTUS: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 426 ZIMMER BIOMET: COMPANY OVERVIEW
  • TABLE 427 ZIMMER BIOMET: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 428 ZIMMER BIOMET: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 429 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 430 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW
  • TABLE 431 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW
  • TABLE 432 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 433 ADVANCIS (UK): COMPANY OVERVIEW
  • TABLE 434 MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 435 PENSAR MEDICAL: COMPANY OVERVIEW
  • TABLE 436 HAROMED BV: COMPANY OVERVIEW
  • TABLE 437 URGO GROUP: COMPANY OVERVIEW
  • TABLE 438 DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW
  • TABLE 439 DERMARITE INDUSTRIES, LLC.: COMPANY OVERVIEW
  • TABLE 440 GENTELL: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 ADVANCED WOUND CARE MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 ADVANCED WOUND CARE MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 ADVANCED WOUND CARE MARKET: TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 ADVANCED WOUND CARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 9 ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 10 ADVANCED WOUND CARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF ADVANCED WOUND CARE MARKET
  • FIGURE 12 INCREASING PREVALENCE OF DIABETES AND GROWING GERIATRIC POPULATION TO DRIVE MARKET
  • FIGURE 13 HOSPITALS, ASCS, AND WOUND CARE CENTERS ACCOUNTED FOR LARGEST SHARE IN 2024
  • FIGURE 14 INDIA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030
  • FIGURE 15 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 16 ADVANCED WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17 ADVANCED WOUND CARE MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 19 ADVANCED WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 20 ADVANCED WOUND CARE MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 21 ADVANCED WOUND CARE MARKET: INVESTMENT AND FUNDING SCENARIO, 2019-2025
  • FIGURE 22 ADVANCED WOUND CARE MARKET: PATENT ANALYSIS, JANUARY 2015-DECEMBER 2024
  • FIGURE 23 ADVANCED WOUND CARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ADVANCED WOUND CARE PRODUCTS
  • FIGURE 25 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS
  • FIGURE 26 AI USE CASES
  • FIGURE 27 NORTH AMERICA: ADVANCED WOUND CARE MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: ADVANCED WOUND CARE MARKET SNAPSHOT
  • FIGURE 29 ADVANCED WOUND CARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2022-2024
  • FIGURE 30 ADVANCED WOUND CARE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
  • FIGURE 31 NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
  • FIGURE 32 ADVANCED WOUND DRESSINGS MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
  • FIGURE 33 RANKING OF KEY PLAYERS IN ADVANCED WOUND CARE MARKET, 2024
  • FIGURE 34 ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 35 ADVANCED WOUND CARE MARKET: COMPANY FOOTPRINT
  • FIGURE 36 ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 38 EV/EBITDA OF KEY VENDORS
  • FIGURE 39 ADVANCED WOUND CARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 40 SOLVENTUM: COMPANY SNAPSHOT (2024)
  • FIGURE 41 SMITH+NEPHEW: COMPANY SNAPSHOT (2024)
  • FIGURE 42 MOLNLYCKE AB: COMPANY SNAPSHOT (2024)
  • FIGURE 43 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 44 COLOPLAST GROUP: COMPANY SNAPSHOT (2024)
  • FIGURE 45 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 46 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024)
  • FIGURE 47 CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
  • FIGURE 48 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 49 OWENS & MINOR: COMPANY SNAPSHOT (2024)
  • FIGURE 50 B. BRAUN SE: COMPANY SNAPSHOT (2024)
  • FIGURE 51 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024)
  • FIGURE 52 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 53 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 54 MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 55 BIOVENTUS: COMPANY SNAPSHOT (2024)
  • FIGURE 56 ZIMMER BIOMET: COMPANY SNAPSHOT (2024)